Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | RXRG | P48443 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.32 |
| ▸ | ATR | Q13535 | 9/20 | 0.32 |
| ▸ | KAT7 | O95251 | 2/20 | 0.32 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.32 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27377578 | 1.00 | ALDH1A1 (0.39) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27371606 | 0.82 | ALDH1A1 (0.42) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27371608 | 0.81 | ALDH1A1 (0.40) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27371860 | 0.79 | CYP4F2 (0.40) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27371856 | 0.79 | ATR (0.43) | ALDH1A1LMNAPOLBATR | |
| SCHEMBL27377479 | 0.77 | ALDH1A1 (0.38) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27376556 | 0.77 | ALDH1A1 (0.46) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27371688 | 0.75 | RXRA (0.41) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27371610 | 0.74 | CYP4F2 (0.38) | ALDH1A1LMNAPOLBRXRARXRB | |
| SCHEMBL27371443 | 0.74 | RXRA (0.45) | ALDH1A1LMNAPOLBRXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085062-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTPR LTD (GB) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085062-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CSNK1A1, CSNK1G1, CSNK2A3 | ALDH1A1 3770/4885LMNA 725/4885POLB 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.